Definitive Healthcare Corp. announced that its Special Committee received a non-binding proposal from Advent International to acquire all outstanding Class A common stock and Definitive OpCo Units not already held by Advent or Executive Chairman Jason Krantz for an all-cash purchase price of $1.02 per share. The company operates in the healthcare market data and analytics industry.

Definitive Healthcare Corp. appointed Clay Ritchey as Chief Executive Officer and a Board member, effective September 8, 2026. Mr. Ritchey succeeds Kevin Coop, who stepped down as CEO and from the Board on August 31, 2026. The new CEO receives an annual base salary of $500,000, a target bonus equal to 87.5% of base salary, and initial equity awards valued at $4,000,000, comprising time-based and performance-based restricted stock units. Definitive Healthcare operates in the healthcare data and analytics industry.

Definitive Healthcare Corp. reported financial results for the second quarter ended June 30, 2026, on August 10, 2026. Revenue decreased 9% to $55.2 million from $60.8 million in the prior year period. The company posted a net loss of $(7.5) million compared to $(9.3) million previously, while adjusted net income was $7.5 million versus $9.7 million. Adjusted EBITDA fell to $14.6 million (26% margin) from $18.7 million (31% margin). Cash flow from operations was $11.5 million and unlevered free cash flow was $11.6 million. The company issued Q3 2026 revenue guidance of $54.0–$55.0 million and full-year 2026 revenue guidance of $220.0–$222.0 million. Definitive Healthcare operates in the healthcare data and analytics industry, providing market intelligence solutions to healthcare organizations.

Definitive Healthcare Corp. received a written notice from Nasdaq notifying the company's common stock no longer meets the minimum bid price requirement of $1.00 per share based on 30 consecutive business days of closing bid prices from May 6, 2026, to June 17, 2026. The company has a 180-day compliance period ending December 15, 2026, to regain compliance, with potential for an additional 180-day period if certain criteria are met. Definitive Healthcare Corp. is a healthcare data and commercial intelligence platform provider.